0001911476-22-000001.txt : 20220222
0001911476-22-000001.hdr.sgml : 20220222
20220218182552
ACCESSION NUMBER: 0001911476-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220218
EFFECTIVENESS DATE: 20220222
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Psammiad Therapeutics, Inc.
CENTRAL INDEX KEY: 0001911476
IRS NUMBER: 853485833
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-434323
FILM NUMBER: 22654368
BUSINESS ADDRESS:
STREET 1: 700 COLORADO BLVD, SUITE #118
CITY: DENVER
STATE: CO
ZIP: 80206
BUSINESS PHONE: 720.820.0005
MAIL ADDRESS:
STREET 1: 700 COLORADO BLVD, SUITE #118
CITY: DENVER
STATE: CO
ZIP: 80206
D
1
primary_doc.xml
X0708
D
LIVE
0001911476
Psammiad Therapeutics, Inc.
700 COLORADO BLVD, SUITE #118
DENVER
CO
COLORADO
80206
720.820.0005
DELAWARE
None
None
Corporation
true
2022
Anthony
Gerber
700 Colorado Blvd, Suite 118
Denver
CO
COLORADO
80206
Executive Officer
Director
Michael
Eber
700 Colorado Blvd, Suite 119
Denver
CO
COLORADO
80206
Executive Officer
Matthew
Veatch
700 Colorado Blvd, Suite 119
Denver
CO
COLORADO
80206
Executive Officer
Biotechnology
No Revenues
- 06b
false
2022-01-31
false
true
Convertible Note
false
10000
3000000
2200000
800000
false
5
0
0
0
true
false
Psammiad Therapeutics, Inc.
Michael Eber
Michael Eber
Treasurer
2022-02-18